STEM vs VRTX · rev $144.6M vs P/E 30, rev $12.00B
Stem Inc (STEM) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
STEM currently screens at market cap $82.1M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the STEM and VRTX stock pages for the full models.
Not investment advice.